[1] رشیدی ل.، شجاع الساداتی س.ع.،
مروری بر کاربرد نانوذرههای مزومتخلخل سیلیکا به عنوان سامانه حمل دارو،
نشریه شیمی و مهندسی شیمی ایران،
(1)37: 11 تا 40 (1397).
[2] امیدی م.، شجاع الساداتی س.ع.، مرسلی ع.،
بررسی بارگذاری و رهایش کنترل شده یک داروی ضد آریتمی قلبی در یک چارچوب فلزـآلی،
نشریه شیمی و مهندسی شیمی ایران،
(2)33: 21 تا 25 (1393).
[3] Arias J.L., “
Nanotechnology and Drug Delivery”, Volume One: Nanoplatforms in Drug Delivery, USA: CRC Press, 1-27 (2014).
[4] Ma1 P., Xiao1 H., Li C., Dai Y., Cheng Z., Hou Z., Jun L.,
Inorganic Nanocarriers for Platinum Drug Delivery,
Inorganic Nanocarriers for Platinum Drug Delivery.,
10(18): 554-564 (2015).
[6] Bennett M., Palumbo J., Scott C., Whitcomb C., “
Enhanced Diffusivity in Metal-Organic Frameworks for Use as a Drug Delivery System”, Project Advisor: Andrew Teixeira, Date: March 2nd, 2018.
[7] Lian X., Fang Y., Joseph E., Wang Q., Li J., Banerjee S., Lollar C., Wang X., Zhou H.,
Enzyme–MOF (Metal–Organic Framework) Composites,
Chem. Soc. Rev., 46(11): 3386-3401 (2017).
[8] Kaura H., Mohanta G.C., Gupta V., Kukkar D., Tyagi S.,
Synthesis and Characterization of ZIF-8 Nanoparticles for Controlled Release of 6-Mercaptopurine Drug,
J. Drug Deliv. Sci. Technol.,
41: 106-112 (2017).
[9] Zhang F.M., Dong H., Zhang X., Sun X., Liu M., Yang D., Liu X., Wei J.,
Postsynthetic Modification of ZIF-90 for Potential Targeted Co-Delivery of Two Anticancer Drugs,
ACS Appl. Mater. Interfaces., 9(32): 27332-21337 (2017).
[10] Jiang K., Zhang L., Hu Q., Zhao D., Xia T., Lin W., Yang Y., Cui Y., Yanga Y., Qian G.,
Pressure-Controlled Drug Release in a Zr-Cluster-based MOF, the Royal Society of Chemistry, J. Mater. Chem. B.,
4(39): 6398-6401 (2016).
[11] AL Haydar M., Rasool Abid H., Sunderland B., Wang S.,
Metal Organic Frameworks as a Drug Delivery System for Flurbiprofen. Drug Des Devel Ther,
Drug Des. Devel. Ther.,
11: 2685-2695 (2017).
[13] Fathi1 M., Kazemi S., Zahedi F., Shiran M.R., Moghadamnia A.A.,
Comparison of Oral Bioavailability of Acetaminophen Tablets, Capsules and Effervescent Dosage Forms in Healthy Volunteers,
Current Issues in Pharmacy and Medical Sciences.,
31(1): 5-9 (2018).
[14] Simmons D.L., Wagner D., Westover K.,
Nonsteroidal Anti-Inflammatory Drugs, Acetaminophen, Cyclooxygenase, and Fever,
Clin. Infect. Dis.,
31(5): S211–S218 (2000).
[15] Gordon J., Kazemian H., Rohani S.,
MIL-53(Fe), MIL-101, and SBA-15 Porous Materials: Potential Platforms for Drug Delivery,
Mater. Sci. Eng. C. Mater. Biol. Appl.,
47: 172–179 (2015).
[17] Lim C.S., Schnobrich J.K., Wong-Foy A.G., J, Matzger A.,
Metal-Dependent Phase Selection in Coordination Polymers Derived from a C2v-Symmetric Tricarboxylate,
Inorg. Chem.,
49(11): 5271–5275 (2010).
[19] Antek G., Foy W., Lebel O., Matzger A.,
Porous Crystal Derived from a Tricarboxylate Linker with Two Distinct Binding Motifs,
J. Am. Chem. Soc.,
129(51): 15740–14741 (2007).
[21] Korsmeyer R.W., Gurny R., Doelker E., Buri P., Peppas N.A.,
Mechanisms of Solute Release from Porous Hydrophilic Polymers,
Int. J. Pharm.,
15(1): 25–35 (1983).
[26] Li Z., Peng Y., Xia X., Cao Z., Deng1 Y., Tang B.,
Sr/ptA Metal Organic Framework as A Drug Delivery System for Osteoarthritis Treatment,
Sci. Rep.,
9: 17570 (2019).
[27] Han Y., Liu W., Huang J., Qiu S., Zhong H., Liu D., Liu J.,
Cyclodextrin-based Metal-Organic Frameworks (CD-MOFs) in Pharmaceutics and Biomedicine,
Pharmaceutics., 10(4) :271 (2018)